Litcius/Paper detail

International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma

Paula Rodríguez‐Otero, Saad Z. Usmani, Adam D. Cohen, Niels W.C.J. van de Donk, Xavier Leleu, Jaime Gállego Pérez‐Larraya, Salomon Manier, Ajay K. Nooka, María‐Victoria Mateos, Hermann Einsele, Monique C. Minnema, Michèle Cavo, Benjamin A. Derman, Noemí Puig, Francesca Gay, P. Joy Ho, Wee Joo Chng, Efstathios Kastritis, Gösta Gahrton, Katja Weisel, Chandramouli Nagarajan, Fredik Schjesvold, Joseph Mıkhael, Luciano J. Costa, Noopur Raje, Elena Zamagni, Roman Hájek, Niels Weinhold, Kwee Yong, Jing Christine Ye, Surbhi Sidana, Giampaolo Merlini, Tom Martin, Yi Lin, Ajai Chari, Rakesh Popat, Jonathan L. Kaufman

2024The Lancet Oncology119 citationsDOIOpen Access PDF

Topics & Concepts

MedicineMultiple myelomaChimeric antigen receptorImmunotherapyClinical trialOncologyAntibodyAntigenImmunologyInternal medicineCancerCAR-T cell therapy researchMonoclonal and Polyclonal Antibodies ResearchBiosimilars and Bioanalytical Methods
International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma | Litcius